A detailed history of Bank & Trust CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Bank & Trust CO holds 1,371 shares of UTHR stock, worth $639,434. This represents 0.42% of its overall portfolio holdings.

Number of Shares
1,371
Previous 1,371 -0.0%
Holding current value
$639,434
Previous $394 Million 45.89%
% of portfolio
0.42%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

BUY
$276.47 - $328.4 $14,376 - $17,076
52 Added 3.94%
1,371 $394 Million
Q2 2024

Jul 08, 2024

BUY
$228.26 - $319.04 $301,074 - $420,813
1,319 New
1,319 $420 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Bank & Trust CO Portfolio

Follow Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bank & Trust CO with notifications on news.